Low prevalence of combined linezolid- and vancomycin-resistant Enterococcus faecium from hospital admission screening in an endemic region in Germany

Background: The emergence and spread of linezolid and combined linezolid/vancomycin resistance in Enterococcus faecium (LVRE) is a major therapeutic challenge. Due to the unavailability of standardized selective culture media for LVRE screening, the detection of LVRE is laborious and costly. Systema...

Full description

Bibliographic Details
Main Authors: Alexandra Heininger, Stefan Zimmermann, Carolin Bootsveld, Sébastien Boutin, Dennis Nurjadi
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716520301296
_version_ 1818455332444176384
author Alexandra Heininger
Stefan Zimmermann
Carolin Bootsveld
Sébastien Boutin
Dennis Nurjadi
author_facet Alexandra Heininger
Stefan Zimmermann
Carolin Bootsveld
Sébastien Boutin
Dennis Nurjadi
author_sort Alexandra Heininger
collection DOAJ
description Background: The emergence and spread of linezolid and combined linezolid/vancomycin resistance in Enterococcus faecium (LVRE) is a major therapeutic challenge. Due to the unavailability of standardized selective culture media for LVRE screening, the detection of LVRE is laborious and costly. Systematic data on LVRE prevalence are scarce, and therefore, supportive evidence for the correct implementation of preemptive strategies is lacking. Objective: We investigated the prevalence of LVRE in a vancomycin-resistant enterococci (VRE) endemic area in Germany in admission screening of high-risk patients for multidrug-resistant organisms to assess the necessity of LVRE screening. Methods: We performed phenotypic testing for linezolid susceptibility in all patients (n = 2572) admitted to our hospital in the months of January, April, July and October 2018 with a positive VRE culture in their rectal admission screening swab. Eight isolates from seven patients with LVRE colonization were characterized by whole genome sequencing. Results: Twenty-eight percent (712/2572) of screened patients were colonized by VRE. Seventy percent (497/712) of the isolates were available for testing and whole genome sequencing. A total of 1.4% (7/497) of VRE were LVRE, predominantly due to mutations of 23S rRNA. optrA, poxtA or cfr genes were not detected. Patients with LVRE colonization did not develop LVRE infections during their stay. Conclusion: LVRE prevalence was low, and there was no evidence for the dissemination of linezolid resistance genes. Due to the low prevalence and the low risk of infection due to endogenous LVRE, we do not see the immediate necessity to introduce routine LVRE screening in our hospital.
first_indexed 2024-12-14T22:09:06Z
format Article
id doaj.art-9214ee8108f34f98b9226be296762404
institution Directory Open Access Journal
issn 2213-7165
language English
last_indexed 2024-12-14T22:09:06Z
publishDate 2020-09-01
publisher Elsevier
record_format Article
series Journal of Global Antimicrobial Resistance
spelling doaj.art-9214ee8108f34f98b9226be2967624042022-12-21T22:45:48ZengElsevierJournal of Global Antimicrobial Resistance2213-71652020-09-0122646650Low prevalence of combined linezolid- and vancomycin-resistant Enterococcus faecium from hospital admission screening in an endemic region in GermanyAlexandra Heininger0Stefan Zimmermann1Carolin Bootsveld2Sébastien Boutin3Dennis Nurjadi4Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University Hospital, Heidelberg, GermanyDepartment of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University Hospital, Heidelberg, GermanyDepartment of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University Hospital, Heidelberg, GermanyDepartment of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University Hospital, Heidelberg, GermanyCorresponding author at: Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University Hospital, Im Neuenheimer Feld 324, 69120 Heidelberg, Germany.; Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University Hospital, Heidelberg, GermanyBackground: The emergence and spread of linezolid and combined linezolid/vancomycin resistance in Enterococcus faecium (LVRE) is a major therapeutic challenge. Due to the unavailability of standardized selective culture media for LVRE screening, the detection of LVRE is laborious and costly. Systematic data on LVRE prevalence are scarce, and therefore, supportive evidence for the correct implementation of preemptive strategies is lacking. Objective: We investigated the prevalence of LVRE in a vancomycin-resistant enterococci (VRE) endemic area in Germany in admission screening of high-risk patients for multidrug-resistant organisms to assess the necessity of LVRE screening. Methods: We performed phenotypic testing for linezolid susceptibility in all patients (n = 2572) admitted to our hospital in the months of January, April, July and October 2018 with a positive VRE culture in their rectal admission screening swab. Eight isolates from seven patients with LVRE colonization were characterized by whole genome sequencing. Results: Twenty-eight percent (712/2572) of screened patients were colonized by VRE. Seventy percent (497/712) of the isolates were available for testing and whole genome sequencing. A total of 1.4% (7/497) of VRE were LVRE, predominantly due to mutations of 23S rRNA. optrA, poxtA or cfr genes were not detected. Patients with LVRE colonization did not develop LVRE infections during their stay. Conclusion: LVRE prevalence was low, and there was no evidence for the dissemination of linezolid resistance genes. Due to the low prevalence and the low risk of infection due to endogenous LVRE, we do not see the immediate necessity to introduce routine LVRE screening in our hospital.http://www.sciencedirect.com/science/article/pii/S2213716520301296LVREVREEpidemiologylinezolid- and vancomycin-resistant Enterococcus faeciumE. faeciumScreening
spellingShingle Alexandra Heininger
Stefan Zimmermann
Carolin Bootsveld
Sébastien Boutin
Dennis Nurjadi
Low prevalence of combined linezolid- and vancomycin-resistant Enterococcus faecium from hospital admission screening in an endemic region in Germany
Journal of Global Antimicrobial Resistance
LVRE
VRE
Epidemiology
linezolid- and vancomycin-resistant Enterococcus faecium
E. faecium
Screening
title Low prevalence of combined linezolid- and vancomycin-resistant Enterococcus faecium from hospital admission screening in an endemic region in Germany
title_full Low prevalence of combined linezolid- and vancomycin-resistant Enterococcus faecium from hospital admission screening in an endemic region in Germany
title_fullStr Low prevalence of combined linezolid- and vancomycin-resistant Enterococcus faecium from hospital admission screening in an endemic region in Germany
title_full_unstemmed Low prevalence of combined linezolid- and vancomycin-resistant Enterococcus faecium from hospital admission screening in an endemic region in Germany
title_short Low prevalence of combined linezolid- and vancomycin-resistant Enterococcus faecium from hospital admission screening in an endemic region in Germany
title_sort low prevalence of combined linezolid and vancomycin resistant enterococcus faecium from hospital admission screening in an endemic region in germany
topic LVRE
VRE
Epidemiology
linezolid- and vancomycin-resistant Enterococcus faecium
E. faecium
Screening
url http://www.sciencedirect.com/science/article/pii/S2213716520301296
work_keys_str_mv AT alexandraheininger lowprevalenceofcombinedlinezolidandvancomycinresistantenterococcusfaeciumfromhospitaladmissionscreeninginanendemicregioningermany
AT stefanzimmermann lowprevalenceofcombinedlinezolidandvancomycinresistantenterococcusfaeciumfromhospitaladmissionscreeninginanendemicregioningermany
AT carolinbootsveld lowprevalenceofcombinedlinezolidandvancomycinresistantenterococcusfaeciumfromhospitaladmissionscreeninginanendemicregioningermany
AT sebastienboutin lowprevalenceofcombinedlinezolidandvancomycinresistantenterococcusfaeciumfromhospitaladmissionscreeninginanendemicregioningermany
AT dennisnurjadi lowprevalenceofcombinedlinezolidandvancomycinresistantenterococcusfaeciumfromhospitaladmissionscreeninginanendemicregioningermany